Research organizations around the world are deploying Simoa to combat COVID-19 and future pandemics with a full range of products, applications, and services including those listed below. In particular, Simoa’s extreme sensitivity and specificity is enabling researchers to measure cytokine levels and profiles in non-critical and critical COVID-19 patients as well as asymptomatic and symptomatic patients.
We are actively seeking partners to work with us to develop viral loading and host immune response assays for both symptomatic and pre-symptomatic patients. Let us know if you have ideas, assays and/or key reagents that could be combined with Simoa’s ultra-sensitivity.
View our recent webinar to learn more about our efforts to prioritize support for COVID-19 research.
Announcing the winners of the Simoa Success Grant Program, aimed at supporting researchers at the intersection of laboratory and clinical research in Infectious Diseases and Immunology. Learn more now!